Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker PG
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Abd El Hak Hesham Officer | PG Procter & Gamble Company | 2,250 | $370.1K | — | Nov 10, 2026 | Form 4 ↗ 3 days later · 2,250 shares | Form 144 ↗ |
| Nov 2, 2026 | Matthew W. Janzaruk Officer | PG Procter & Gamble Company | 9,479 | $1.5M | — | Nov 3, 2026 | Form 4 ↗ 1 day later · 9,479 shares | Form 144 ↗ |
| Nov 2, 2026 | Andre Schulten Officer | PG Procter & Gamble Company | 64,301 | $10.5M | — | Nov 3, 2026 | Form 4 ↗ 3 days later · 33,624 shares | Form 144 ↗ |
| Oct 29, 2026 | Moses Victor Javier Aguilar Officer | PG Procter & Gamble Company | 18,812 | $3.0M | — | Oct 30, 2026 | Form 4 ↗ 5 days later · 18,812 shares | Form 144 ↗ |
| Oct 26, 2026 | Santos de Azevedo Juliana Monteiro Officer | PG Procter & Gamble Company | 5,370 | $873.0K | — | Oct 27, 2026 | Form 4 ↗ 14 days later · 5,370 shares | Form 144 ↗ |
| Oct 22, 2026 | Paul Gama Officer | PG Procter & Gamble Company | 14,623 | $2.3M | — | Oct 23, 2026 | Form 4 ↗ 4 days later · 4,331 shares | Form 144 ↗ |
| Oct 22, 2026 | Jejurikar Shailesh Officer, Director | PG Procter & Gamble Company | 35,000 | $5.5M | — | Oct 23, 2026 | Form 4 ↗ 4 days later · 35,000 shares | Form 144 ↗ |
| Oct 22, 2026 | Purushothaman Balaji Officer | PG Procter & Gamble Company | 4,181 | $659.5K | — | Oct 23, 2026 | Form 4 ↗ 4 days later · 4,181 shares | Form 144 ↗ |
| Oct 22, 2026 | Sundar G. Raman Officer | PG Procter & Gamble Company | 38,253 | $6.0M | — | Oct 23, 2026 | Form 4 ↗ 12 days later · 38,253 shares | Form 144 ↗ |
| Oct 1, 2026 | Jon R. Moeller Officer, Director | PG Procter & Gamble Company | 8,087 | $1.2M | — | Oct 2, 2026 | — | Form 144 ↗ |
| Oct 1, 2026 | Whaley Susan Street Officer | PG Procter & Gamble Company | 2,817 | $416.5K | — | Oct 2, 2026 | — | Form 144 ↗ |
| Oct 1, 2026 | Andre Schulten Officer | PG Procter & Gamble Company | 4,655 | $688.2K | — | Oct 2, 2026 | Form 4 ↗ 35 days later · 33,624 shares | Form 144 ↗ |
| Oct 1, 2026 | Paul Gama Officer | PG Procter & Gamble Company | 2,646 | $391.2K | — | Oct 2, 2026 | Form 4 ↗ 25 days later · 4,331 shares | Form 144 ↗ |
| Aug 24, 2026 | Paul Gama Officer | PG Procter & Gamble Company | 4,331 | $622.4K | — | Aug 25, 2026 | Form 4 ↗ 63 days later · 4,331 shares | Form 144 ↗ |
| Aug 21, 2026 | Matthew W. Janzaruk Officer | PG Procter & Gamble Company | 359 | $51.6K | — | Aug 24, 2026 | Form 4 ↗ 3 days later · 359 shares | Form 144 ↗ |
| Aug 18, 2026 | Santos de Azevedo Juliana Monteiro Officer | PG Procter & Gamble Company | 2,889 | $416.5K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 2,368 shares | Form 144 ↗ |
| Aug 18, 2026 | Sundar G. Raman Officer | PG Procter & Gamble Company | 3,772 | $543.8K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 3,435 shares | Form 144 ↗ |
| Aug 18, 2026 | Purushothaman Balaji Officer | PG Procter & Gamble Company | 2,450 | $353.2K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 2,019 shares | Form 144 ↗ |
| Aug 18, 2026 | Andre Schulten Officer | PG Procter & Gamble Company | 6,569 | $947.0K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 5,402 shares | Form 144 ↗ |
| Aug 18, 2026 | Whaley Susan Street Officer | PG Procter & Gamble Company | 2,858 | $412.0K | — | Aug 19, 2026 | Form 4 ↗ 2 days later · 8,644 shares | Form 144 ↗ |
| Aug 18, 2026 | Marc S. Pritchard Officer | PG Procter & Gamble Company | 4,572 | $659.1K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 4,030 shares | Form 144 ↗ |
| Aug 18, 2026 | Jon R. Moeller Director | PG Procter & Gamble Company | 22,612 | $3.3M | — | Aug 19, 2026 | — | Form 144 ↗ |
| Aug 18, 2026 | Matthew W. Janzaruk Officer | PG Procter & Gamble Company | 189 | $27.2K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 156 shares | Form 144 ↗ |
| Aug 18, 2026 | Jejurikar Shailesh Officer, Director | PG Procter & Gamble Company | 7,506 | $1.1M | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 6,176 shares | Form 144 ↗ |
| Aug 18, 2026 | Abd El Hak Hesham Officer | PG Procter & Gamble Company | 2,354 | $339.4K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 1,936 shares | Form 144 ↗ |
| Aug 18, 2026 | Paul Gama Officer | PG Procter & Gamble Company | 4,113 | $593.0K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 3,396 shares | Form 144 ↗ |
| Aug 18, 2026 | Freddy P. Bharucha Officer | PG Procter & Gamble Company | 299 | $43.1K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 246 shares | Form 144 ↗ |
| Aug 18, 2026 | Moses Victor Javier Aguilar Officer | PG Procter & Gamble Company | 3,698 | $533.1K | — | Aug 19, 2026 | Form 4 ↗ 6 days later · 3,053 shares | Form 144 ↗ |
| Aug 5, 2026 | Whaley Susan Street Officer | PG Procter & Gamble Company | 8,644 | $1.3M | — | Aug 6, 2026 | Form 4 ↗ 15 days later · 8,644 shares | Form 144 ↗ |
| Feb 18, 2026 | Whaley Susan Street Officer | PG Procter & Gamble Company | 1,809 | $290.4K | — | Feb 19, 2026 | Form 4 ↗ 5 days later · 1,809 shares | Form 144 ↗ |
| Feb 13, 2026 | Moses Victor Javier Aguilar Officer | PG Procter & Gamble Company | 15,169 | $2.4M | — | Feb 13, 2026 | Form 4 ↗ 4 days later · 15,169 shares | Form 144 ↗ |
| Feb 10, 2026 | Purushothaman Balaji Officer | PG Procter & Gamble Company | 12,827 | $2.0M | — | Feb 11, 2026 | Form 4 ↗ 3 days later · 12,827 shares | Form 144 ↗ |
| Feb 10, 2026 | Jon R. Moeller Officer, Director | PG Procter & Gamble Company | 173,268 | $27.3M | — | Feb 11, 2026 | Form 4 ↗ 3 days later · 173,268 shares | Form 144 ↗ |
| Feb 9, 2026 | Keith R. Alexandra Officer, Member of immediate family of… | PG Procter & Gamble Company | 558 | $88.7K | — | Feb 10, 2026 | — | Form 144 ↗ |
| Feb 9, 2026 | Keith R. Alexandra Officer, Member of immediate family of… | PG Procter & Gamble Company | 2,215 | $352.2K | — | Feb 10, 2026 | — | Form 144 ↗ |
| Feb 3, 2026 | Gary A. Coombe Officer | PG Procter & Gamble Company | 72,186 | $11.0M | — | Feb 4, 2026 | Form 4 ↗ 10 days later · 36,093 shares | Form 144 ↗ |
| Jan 28, 2026 | Francisco Ma. Fatima Officer | PG Procter & Gamble Company | 13,549 | $2.0M | — | Jan 29, 2026 | Form 4 ↗ 7 days later · 8,000 shares | Form 144 ↗ |
| Jan 22, 2026 | Marc S. Pritchard Officer | PG Procter & Gamble Company | 95,903 | $14.0M | — | Jan 23, 2026 | Form 4 ↗ 4 days later · 95,903 shares | Form 144 ↗ |
| Oct 29, 2025 | Matthew W. Janzaruk Officer | PG Procter & Gamble Company | 725 | $110.1K | — | Oct 30, 2025 | Form 4 ↗ 1 day later · 725 shares | Form 144 ↗ |
| Sep 30, 2025 | Whaley Susan Street Officer | PG Procter & Gamble Company | 2,864 | $435.6K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 2,408 shares | Form 144 ↗ |
| Sep 30, 2025 | Jennifer L. Davis Officer | PG Procter & Gamble Company | 3,837 | $583.6K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 3,227 shares | Form 144 ↗ |
| Sep 30, 2025 | Jejurikar Shailesh Officer | PG Procter & Gamble Company | 4,739 | $720.8K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 3,986 shares | Form 144 ↗ |
| Sep 30, 2025 | Gary A. Coombe Officer | PG Procter & Gamble Company | 4,203 | $639.3K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 3,535 shares | Form 144 ↗ |
| Sep 30, 2025 | Jon R. Moeller Officer, Director | PG Procter & Gamble Company | 13,893 | $2.1M | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 11,684 shares | Form 144 ↗ |
| Sep 30, 2025 | Keith R. Alexandra Officer | PG Procter & Gamble Company | 2,206 | $335.5K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 2,254 shares | Form 144 ↗ |
| Sep 30, 2025 | Keith R. Alexandra Officer | PG Procter & Gamble Company | 474 | $72.1K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 2,254 shares | Form 144 ↗ |
| Sep 30, 2025 | Purushothaman Balaji Officer | PG Procter & Gamble Company | 582 | $88.5K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 490 shares | Form 144 ↗ |
| Sep 30, 2025 | Andre Schulten Officer | PG Procter & Gamble Company | 5,056 | $769.0K | — | Oct 2, 2025 | Form 4 ↗ 6 days later · 4,252 shares | Form 144 ↗ |
| Aug 28, 2025 | Whaley Susan Street Officer | PG Procter & Gamble Company | 1,000 | $156.5K | — | Aug 29, 2025 | Form 4 ↗ 1 day later · 1,000 shares | Form 144 ↗ |
| Aug 20, 2025 | Keith R. Alexandra Officer | PG Procter & Gamble Company | 11,128 | $1.7M | — | Aug 21, 2025 | Form 4 ↗ 2 days later · 11,463 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:14 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances